ADVERSE EFFECT OF TAMOXIFEN WITH LHRH AGONIST ON OESTROGEN-RECEPTOR-NEGATIVE MAMMARY CARCINOMA

B. Szende, AndrewV Schally, Gordan Srkalovic, AnaMaria Comaru-Schally, JamesL Wittliff

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)222-223
Number of pages2
JournalThe Lancet
Volume334
Issue number8656
DOIs
Publication statusPublished - Jul 22 1989

Fingerprint

Experimental Mammary Neoplasms
Inbred Strains Mice
Tamoxifen
Combination Drug Therapy
Gonadotropin-Releasing Hormone
Estrogen Receptors
Estrogens
Adenocarcinoma
Breast Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

ADVERSE EFFECT OF TAMOXIFEN WITH LHRH AGONIST ON OESTROGEN-RECEPTOR-NEGATIVE MAMMARY CARCINOMA. / Szende, B.; Schally, AndrewV; Srkalovic, Gordan; Comaru-Schally, AnaMaria; Wittliff, JamesL.

In: The Lancet, Vol. 334, No. 8656, 22.07.1989, p. 222-223.

Research output: Contribution to journalArticle

Szende, B. ; Schally, AndrewV ; Srkalovic, Gordan ; Comaru-Schally, AnaMaria ; Wittliff, JamesL. / ADVERSE EFFECT OF TAMOXIFEN WITH LHRH AGONIST ON OESTROGEN-RECEPTOR-NEGATIVE MAMMARY CARCINOMA. In: The Lancet. 1989 ; Vol. 334, No. 8656. pp. 222-223.
@article{3f3f1a2eec3f4a028ffe955b724b41e4,
title = "ADVERSE EFFECT OF TAMOXIFEN WITH LHRH AGONIST ON OESTROGEN-RECEPTOR-NEGATIVE MAMMARY CARCINOMA",
author = "B. Szende and AndrewV Schally and Gordan Srkalovic and AnaMaria Comaru-Schally and JamesL Wittliff",
year = "1989",
month = "7",
day = "22",
doi = "10.1016/S0140-6736(89)90409-1",
language = "English",
volume = "334",
pages = "222--223",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8656",

}

TY - JOUR

T1 - ADVERSE EFFECT OF TAMOXIFEN WITH LHRH AGONIST ON OESTROGEN-RECEPTOR-NEGATIVE MAMMARY CARCINOMA

AU - Szende, B.

AU - Schally, AndrewV

AU - Srkalovic, Gordan

AU - Comaru-Schally, AnaMaria

AU - Wittliff, JamesL

PY - 1989/7/22

Y1 - 1989/7/22

UR - http://www.scopus.com/inward/record.url?scp=0024409818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024409818&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(89)90409-1

DO - 10.1016/S0140-6736(89)90409-1

M3 - Article

C2 - 2568553

AN - SCOPUS:0024409818

VL - 334

SP - 222

EP - 223

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8656

ER -